THOMAS CLARK: Open Payments
NPI 1295741114 · PROVIDENCE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$55,328 in 158 payments from 22 companies in 2025. Trend: 2023 $55,864 · 2024 $60,237 · 2025 $55,328
Speaker / faculty: $33,593Speaker / faculty: $7,069Travel & lodging: $6,610Consulting: $5,225Food & beverage: $2,746Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 65 | $34,148 |
| Abbott Laboratories | 28 | $15,728 |
| Corcept Therapeutics | 15 | $4,150 |
| Novo Nordisk Inc | 13 | $377 |
| SANOFI-AVENTIS U.S. LLC | 3 | $168 |
| Medtronic, Inc. | 10 | $161 |
| Insulet Corporation | 1 | $130 |
| Dexcom, Inc. | 4 | $90 |
| Exact Sciences Corporation | 3 | $50 |
| BETA BIONICS, INC. | 3 | $50 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, Korlym, TZIELD, Ozempic, OMNIPOD, MINIMED 780G, Wegovy.
Industry payments across UT — which companies pay providers there.
